Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Solv Wellness®, the Pioneers of Clinically Proven UTI Prevention, Introduces GennaMD™: The Next Generation of UTI Defense™

Solv Wellness (PRNewsfoto/Solv Wellness®)

News provided by

Solv Wellness®

Apr 22, 2025, 08:53 ET

Share this article

Share toX

Share this article

Share toX

ATLANTA, April 22, 2025 /PRNewswire/ -- Solv Wellness, a leader in women's menopause and pelvic health, is proud to announce the launch of GennaMD, its latest innovation in urinary tract infection (UTI) management. Building on its legacy as the first company to introduce a clinically proven 36 mg PAC (proanthocyanidin) cranberry supplement to the US market in 2010, Solv Wellness is setting the new standard for UTI management with GennaMD.

Continue Reading
NEW GennaMD™ by Solv Wellness®—The Next Generation of UTI Defense™. Urologist-recommended GennaMD contains 36 mg of soluble PAC from pure cranberry juice extract. Due to a refined extraction process, it offers maximum defense in the smallest UTI supplement available.
NEW GennaMD™ by Solv Wellness®—The Next Generation of UTI Defense™. Urologist-recommended GennaMD contains 36 mg of soluble PAC from pure cranberry juice extract. Due to a refined extraction process, it offers maximum defense in the smallest UTI supplement available.

For the last 15 years, Solv Wellness has been at the forefront of clinically proven UTI management, gaining the trust of leading urologists. Staying in the forefront of UTI management requires innovation, and they have done just that by partnering directly with botanical ingredient suppliers to deliver a new, more advanced, and affordable solution for UTI sufferers. The result is GennaMD, the next generation of UTI defense.

"I am enthusiastic to recommend GennaMD for my patients, which provides the trusted soluble PAC ingredient we have used for over a decade for urinary tract infection prevention, in an even more concentrated formulation," said Melissa Kaufman, MD, PhD, FACS, Professor of Urology, Vanderbilt University.

GennaMD builds on years of proven science and rigorous research.

  • The Same Proven 36 mg PAC from Cranberry Juice Extract, Only Better. A refined extraction process allows for a higher PAC concentration that is 2x more concentrated than that of most other supplements, providing maximum bacteria-fighting power. While most other supplements contain <1%-18% PAC concentration, GennaMD contains 30%, making it the highest PAC concentration available.
  • Maximum Bacteria-Fighting Power in the Smallest Capsule. Proprietary bioPAC™ ingredient provides the highest bacterial anti-adhesion activity per milligram of any other UTI supplement with no unnecessary fillers, making it the smallest UTI supplement available.
  • High Efficacy at a Lower Price. By partnering directly with botanical suppliers, and due to the advancements in its manufacturing process, Solv Wellness is able to offer a powerful supplement at a lower price.
  • Backed by 24 Clinical Studies and Recommended by Leading Urologists Nationwide. Three studies support GennaMD's bioPAC ingredient and 21 studies support soluble cranberry juice-based PAC for UTI prevention.

"Solv Wellness has consistently delivered on high-quality, reliable products to improve the lives of those suffering with recurrent UTIs," said Seth Cohen, MD, FACS, Urogynecology and Reconstructive Pelvic Surgery, Assistant Clinical Professor, City of Hope. "I am excited to have GennaMD available for patients; with its smaller capsule and increased potency, this innovation provides us with a compelling tool to advance UTI prophylaxis regimens."

A Legacy of Leadership in Women's Health
Since its inception in 2010 with the launch of the first clinically proven UTI supplement, Solv Wellness has been dedicated to delivering science-backed solutions for women in menopause and beyond, starting with UTI prevention. Over two decades of clinical research have demonstrated the superior efficacy of 36 mg of soluble PAC that is derived from pure cranberry juice extract to prevent bacterial adhesion in the bladder. With GennaMD, an advanced 36 mg soluble PAC supplement, Solv Wellness reaffirms its leadership in the category they pioneered while advancing its mission to use science to arm women with the tools and knowledge they need to confidently advocate for themselves and feel better in their bodies.

"Antibiotic resistance is a growing concern globally," said Terri Wade, CEO of Solv Wellness. "With GennaMD, we are not only reaffirming our commitment to raise the bar for evidence-based UTI solutions, but also embarking on an ambitious plan to make effective non-antibiotic UTI prevention more accessible for UTI sufferers around the globe."

About Solv Wellness
Since 2010, Solv Wellness has been a pioneer for women's menopausal health by providing meaningful solutions, backed by science, to the often-stigmatized pelvic health issues that women experience at midlife and beyond. Solv Wellness is the company behind GennaMD™, Via®, and Māge®. GennaMD is their latest innovation in UTI management, containing clinically proven 36 mg soluble PAC in the smallest UTI supplement available, with maximum bacteria-fighting power per milligram. Via is a non-hormonal vaginal moisturizer, featuring hyaluronic acid and made with the highest-quality ingredients to help supplement a women's natural moisture. Māge is a state-of-the-art probiotic that helps support the entire female pelvic triangle: the gut, vagina, and urinary tract.

For more information about Solv Wellness and its product offerings, visit solvwellness.com.
For scientific data, dosing information, and more, visit hcp.solvwellness.com.

For press-related inquires:
Candice Mailman
Director of Marketing
[email protected]
609-731-9646

Statements in this release have not been evaluated by the FDA.
These products are not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Solv Wellness®

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Solv Wellness® Launches Menopause Made Clear™ to Tackle Critical Gaps in Menopause

Solv Wellness® Launches Menopause Made Clear™ to Tackle Critical Gaps in Menopause

While every woman who lives long enough will experience menopause, it is one of the most misunderstood and underserved areas of healthcare. Less than ...

More Releases From This Source

Explore

Infection Control

Infection Control

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Supplementary Medicine

Supplementary Medicine

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.